Tranylcypromine, a drug for treating depression finally has got approval from the U.S. Food and Drug Administration’s (FDA).
This is the sulfate tablet of 10mg. The drug is the nonspecific version of GlaxoSmithKline’s parnate. Par Pharmaceutical Companies Inc owns Kali Laboratories Inc. who made the drug.
Read
Tranylcypromine gets FDA approval as depression drug
Add Your Comment
Instablogs Club
Fresh Comments
on Childhood depression to... yes this can epidemic if unchecked
on Suicide rate among elderly... great statistic report
on Today's youth experiencing... these make high stress
on Today's youth experiencing... Yes, there are so many things to worry nowadays, I am not surprised people are more...
on Suicide rate among elderly... Suicide rate among elderly rises coz of love and respect, some are in financial problem.
To Advertise please Contact Us.